PAG
AMED

Private Advisor Group’s Amedisys AMED Stock Holding History

Private Advisor Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,580
Closed -$1.05M – 1892
2020
Q4 		$1.05M Buy
+3,580
New +$918K 0.01% 882
2020
Q3 		– Sell
-406
Closed -$81K – 1634
2020
Q2 		$81K Buy
+406
New +$75.7K ﹤0.01% 1834
2020
Q1 		– Sell
-2,041
Closed -$340K – 1426
2019
Q4 		$340K Buy
+2,041
New +$304K 0.01% 1218
2019
Q3 		– Sell
-2,846
Closed -$346K – 1660
2019
Q2 		$346K Sell
2,846
-425
-13% -$50.4K 0.01% 1212
2019
Q1 		$403K Buy
3,271
+733
+29% +$92K 0.01% 1055
2018
Q4 		$297K Buy
+2,538
New +$299K 0.01% 1025

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Private Advisor Group's AMED Position: Q1 2021 in Review

Private Advisor Group sold out of Amedisys (AMED) in Q1 2021, closing a stake of 3,580 shares — an estimated $1.05M sold.

Private Advisor Group first reported a position in AMED in Q4 2018 and held it in 6 quarters. The position peaked at $1.05M in Q4 2020. 388 funds tracked by Wall St. Rank hold AMED as of Q1 2021.

  • Private Advisor Group reported no remaining Amedisys position as of Q1 2021 after selling out during the quarter.
  • Private Advisor Group sold 3,580 Amedisys shares in Q1 2021, an estimated $1.05M.
  • Private Advisor Group first reported a position in Amedisys in Q4 2018 and held it in 6 quarters.
  • Private Advisor Group's Amedisys position peaked at $1.05M in Q4 2020.
  • 388 funds tracked by Wall St. Rank held Amedisys as of Q1 2021.

Based on Private Advisor Group's 13F filing for Q1 2021, filed 22 Apr 2021.